Search Results - "SHENGLAN TANG"

Refine Results
  1. 1

    Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data by Zhao, Yang, Atun, Rifat, Oldenburg, Brian, McPake, Barbara, Tang, Shenglan, Mercer, Stewart W, Cowling, Thomas E, Sum, Grace, Qin, Vicky Mengqi, Lee, John Tayu

    Published in The Lancet global health (01-06-2020)
    “…Multimorbidity, the presence of two or more mental or physical chronic non-communicable diseases, is a major challenge for the health system in China, which…”
    Get full text
    Journal Article
  2. 2

    Systematic review on irrational use of medicines in China and Vietnam by Mao, Wenhui, Vu, Huyen, Xie, Zening, Chen, Wen, Tang, Shenglan

    Published in PloS one (20-03-2015)
    “…Irrational use of medicines has been an issue concerned all over the world and the outlooks in developing countries are more severe. This study aimed to assess…”
    Get full text
    Journal Article
  3. 3

    The recent advancements of ferroptosis of gynecological cancer by Tang, Shenglan, Chen, Li

    Published in Cancer cell international (26-10-2024)
    “…Ovarian, endometrial, and cervical cancer are the most common types of gynecologic tumor in women. Surgery, combined with radiotherapy and chemotherapy, is…”
    Get full text
    Journal Article
  4. 4

    Addressing cancer care in low- to middle-income countries: a call for sustainable innovations and impactful research by Stefan, D. Cristina, Tang, Shenglan

    Published in BMC cancer (15-08-2023)
    “…Abstract Most new cancer cases are currently arising in low- and middle-income countries, where their outcomes are significantly poorer compared to high-income…”
    Get full text
    Journal Article
  5. 5

    Health System Reform in China 1 Tackling the challenges to health equity in China by SHENGLAN TANG, QINGYUE MENG, CHEN, Lincoln, BEKEDAM, Henk, EVANS, Tim, WHITEHEAD, Margaret

    Published in The Lancet (British edition) (25-10-2008)
    “…In terms of economic development, China is widely acclaimed as a miracle economy. Over a period of rapid economic growth, however, China's reputation for…”
    Get full text
    Journal Article
  6. 6

    Impact of Community-Based DOT on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis by Zhang, HaiYang, Ehiri, John, Yang, Huan, Tang, Shenglan, Li, Ying

    Published in PloS one (05-02-2016)
    “…Poor adherence to tuberculosis (TB) treatment can lead to prolonged infectivity and poor treatment outcomes. Directly observed treatment (DOT) seeks to improve…”
    Get full text
    Journal Article
  7. 7

    China's distinctive engagement in global health by Liu, Peilong, Prof, Guo, Yan, Prof, Qian, Xu, Prof, Tang, Shenglan, Prof, Li, Zhihui, MS, Chen, Lincoln, Prof

    Published in The Lancet (British edition) (30-08-2014)
    “…Summary China has made rapid progress in four key domains of global health. China's health aid deploys medical teams, constructs facilities, donates drugs and…”
    Get full text
    Journal Article
  8. 8

    Reform of how health care is paid for in China: challenges and opportunities by Hu, Shanlian, Prof, Tang, Shenglan, PhD, Liu, Yuanli, Zhao, Yuxin, Escobar, Maria-Luisa, PhD, de Ferranti, David, PhD

    Published in The Lancet (British edition) (22-11-2008)
    “…Summary China's current strategy to improve how health services are paid for is headed in the right direction, but much more remains to be done. The problems…”
    Get full text
    Journal Article
  9. 9

    Tackling the challenges to health equity in China by Tang, Shenglan, PhD, Meng, Qingyue, PhD, Chen, Lincoln, MD, Bekedam, Henk, MD, Evans, Tim, MD, Whitehead, Margaret, Prof

    Published in The Lancet (British edition) (01-01-2008)
    “…Summary In terms of economic development, China is widely acclaimed as a miracle economy. Over a period of rapid economic growth, however, China's reputation…”
    Get full text
    Journal Article
  10. 10

    Ending tuberculosis in China: health system challenges by Long, Qian, Guo, Lei, Jiang, Weixi, Huan, Shitong, Tang, Shenglan

    Published in The Lancet. Public health (01-12-2021)
    “…China has made remarkable progress in reducing tuberculosis cases and deaths during the past three decades; however, it is still far from achieving the targets…”
    Get full text
    Journal Article
  11. 11

    Under-reporting of TB cases and associated factors: a case study in China by Zhou, Danju, Pender, Michelle, Jiang, Weixi, Mao, Wenhui, Tang, Shenglan

    Published in BMC public health (11-12-2019)
    “…Tuberculosis is a leading cause of death worldwide and has become a high global health priority. Accurate country level surveillance is critical to ending the…”
    Get full text
    Journal Article
  12. 12

    Cost Drivers and Financial Burden for Cancer-Affected Families in China: A Systematic Review by Jia, Yufei, Jiang, Weixi, Yang, Bolu, Tang, Shenglan, Long, Qian

    Published in Current oncology (Toronto) (01-08-2023)
    “…This systematic review examined cancer care costs, the financial burden for patients, and their economic coping strategies in mainland China. We included 38…”
    Get full text
    Journal Article
  13. 13

    Achieving SDG related sexual and reproductive health targets in China: what are appropriate indicators and how we interpret them? by Fang, Jing, Tang, Shenglan, Tan, Xiaoping, Tolhurst, Rachel

    Published in Reproductive health (01-06-2020)
    “…Sexual and Reproductive Health (SRH) targets have been included as part of the United Nations Sustainable Development Goals and indictors are important to…”
    Get full text
    Journal Article
  14. 14

    Patient delay, diagnosis delay, and treatment outcomes among migrant patients with tuberculosis in Shanghai, China, 2018-2020: a mixed-methods study by Jia, Yufei, Jiang, Weixi, Xiao, Xiao, Lou, Zhexun, Tang, Shenglan, Chen, Jing, Long, Qian

    Published in BMJ open (26-10-2024)
    “…This study aimed to examine patient delay, diagnosis delay and treatment performance among patients with tuberculosis (TB) in Shanghai, China in 2018-2020…”
    Get full text
    Journal Article
  15. 15

    Changes in health expenditures in China in 2000s: has the health system reform improved affordability by Long, Qian, Xu, Ling, Bekedam, Henk, Tang, Shenglan

    Published in International journal for equity in health (13-06-2013)
    “…China's health system reform launched in early 2000s has achieved better coverage of health insurance and significantly increased the use of healthcare for…”
    Get full text
    Journal Article
  16. 16

    Residential greenness and mortality in oldest-old women and men in China: a longitudinal cohort study by Ji, John S, Zhu, Anna, Bai, Chen, Wu, Chih-Da, Yan, Lijing, Tang, Shenglan, Zeng, Yi, James, Peter

    Published in The Lancet. Planetary health (01-01-2019)
    “…Exposure to natural vegetation, or greenness, might affect health through several pathways, including increased physical activity and social engagement,…”
    Get full text
    Journal Article
  17. 17

    Socio-Economic and Rural-Urban Differences in Healthcare and Catastrophic Health Expenditure Among Cancer Patients in China: Analysis of the China Health and Retirement Longitudinal Study by Zhao, Yang, Tang, Shenglan, Mao, Wenhui, Akinyemiju, Tomi

    Published in Frontiers in public health (11-01-2022)
    “…In China, cancer accounts for one-fifth of all deaths, and exerts a heavy toll on patients, families, healthcare systems, and society as a whole. This study…”
    Get full text
    Journal Article
  18. 18

    Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China by Mao, Wenhui, Tang, Shenglan, Zhu, Ying, Xie, Zening, Chen, Wen

    Published in International journal for equity in health (10-10-2017)
    “…Cancer accounts for one-fifth of the total deaths in China and brings heavy financial burden to patients and their families. Chinese government has made strong…”
    Get full text
    Journal Article
  19. 19

    The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review by Jiang, Mingzhu, Chen, Shu, Yan, Xuanxuan, Ying, Xiaohua, Tang, Shenglan

    Published in Infectious diseases of poverty (08-12-2023)
    “…Non-National Immunization Program (NIP) vaccines have played an important role in controlling vaccine-preventable diseases (VPDs) in China. However, these…”
    Get full text
    Journal Article
  20. 20

    Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action by Li, Jiuling, Chen, Shu, Asturias, Edwin, Tang, Shenglan, Cui, Fuqiang

    Published in Infectious diseases of poverty (01-02-2024)
    “…Many countries have adopted higher-valent pediatric combination vaccines to simplify vaccination schedules and minimize health expenditures and social costs…”
    Get full text
    Journal Article